Fulvestrant for the Treatment of Pulmonary Arterial Hypertension.
作者信息
Kawut Steven M, Pinder Diane, Al-Naamani Nadine, McCormick Amber, Palevsky Harold I, Fritz Jason, Smith K Akaya, Mazurek Jeremy A, Doyle Margaret F, MacLean Margaret R, DeMichele Angela, Mankoff David A
机构信息
Perelman School of Medicine at the University of PennsylvaniaPhiladelphia, Pennsylvania.
University of VermontBurlington, Vermontand.
出版信息
Ann Am Thorac Soc. 2019 Nov;16(11):1456-1459. doi: 10.1513/AnnalsATS.201904-328RL.
Abstract
摘要
相似文献
1
Fulvestrant for the Treatment of Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2019 Nov;16(11):1456-1459. doi: 10.1513/AnnalsATS.201904-328RL.
2
Fulvestrant plus anastrozole for metastatic breast cancer.
Lancet Oncol. 2019 May;20(5):e247. doi: 10.1016/S1470-2045(19)30217-7. Epub 2019 Apr 4.
3
Multicenter Observational Study of Fulvestrant 500 mg in Postmenopausal Japanese Women with Estrogen Receptor-Positive Advanced or Recurrent Breast Cancer after Prior Endocrine Treatment (SBCCSG29 Study).
J Nippon Med Sch. 2019;86(3):165-171. doi: 10.1272/jnms.JNMS.2019_86-305.
4
Abemaciclib plus fulvestrant for breast cancer.
Lancet Oncol. 2019 Nov;20(11):e617. doi: 10.1016/S1470-2045(19)30629-1. Epub 2019 Oct 3.
5
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial.
Lancet Oncol. 2020 Jun;21(6):763-775. doi: 10.1016/S1470-2045(20)30112-1. Epub 2020 Apr 27.
6
Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical Trial.
JAMA Oncol. 2019 Feb 1;5(2):e184475. doi: 10.1001/jamaoncol.2018.4475. Epub 2019 Feb 14.
7
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
N Engl J Med. 2019 Mar 28;380(13):1226-1234. doi: 10.1056/NEJMoa1811714.
8
Fulvestrant-induced toxic epidermal necrolysis.
An Bras Dermatol. 2019 Mar-Apr;94(2):218-220. doi: 10.1590/abd1806-4841.20197964. Epub 2019 May 9.
9
A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
Breast Cancer. 2019 Nov;26(6):703-711. doi: 10.1007/s12282-019-00973-4. Epub 2019 May 11.
10
Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant.
Cancer Med. 2019 Oct;8(14):6212-6220. doi: 10.1002/cam4.2453. Epub 2019 Aug 2.
引用本文的文献
1
Sex differences in pulmonary (arterial) hypertension: does it matter?
Curr Opin Pulm Med. 2025 Sep 1;31(5):411-428. doi: 10.1097/MCP.0000000000001197. Epub 2025 Jul 23.
2
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes.
Cell Mol Biol Lett. 2024 Dec 18;29(1):155. doi: 10.1186/s11658-024-00671-w.
3
Pulmonary Hypertension and Hyperglycemia-Not a Sweet Combination.
Diagnostics (Basel). 2024 May 28;14(11):1119. doi: 10.3390/diagnostics14111119.
4
Behavior of Hypertrophied Right Ventricle during the Development of Left Ventricular Failure Due to Myocardial Infarction.
Int J Mol Sci. 2024 Feb 23;25(5):2610. doi: 10.3390/ijms25052610.
5
A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
Am J Cardiovasc Drugs. 2024 Jan;24(1):39-54. doi: 10.1007/s40256-023-00613-5. Epub 2023 Nov 9.
6
Sex-biased TGFβ signalling in pulmonary arterial hypertension.
Cardiovasc Res. 2023 Oct 24;119(13):2262-2277. doi: 10.1093/cvr/cvad129.
7
SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics.
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1055-1069. doi: 10.1164/rccm.202203-0450OC.
8
A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolism.
Pulm Circ. 2022 Jul 1;12(3):e12139. doi: 10.1002/pul2.12139. eCollection 2022 Jul.
9
Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials.
Ann Am Thorac Soc. 2023 Jan;20(1):58-66. doi: 10.1513/AnnalsATS.202203-207OC.
10
Sex Differences in Pulmonary Hypertension.
Front Aging. 2021 Oct 4;2:727558. doi: 10.3389/fragi.2021.727558. eCollection 2021.
本文引用的文献
1
Role of the Aryl Hydrocarbon Receptor/ARNT/Cytochrome P450 System in Pulmonary Vascular Diseases.
Circ Res. 2019 Jul 19;125(3):356-366. doi: 10.1161/CIRCRESAHA.119.315054. Epub 2019 Jun 26.
2
Derivatization enhances analysis of estrogens and their bioactive metabolites in human plasma by liquid chromatography tandem mass spectrometry.
Anal Chim Acta. 2019 Apr 25;1054:84-94. doi: 10.1016/j.aca.2018.12.023. Epub 2018 Dec 21.
3
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
Eur Respir J. 2018 Jun 28;51(6). doi: 10.1183/13993003.00467-2018. Print 2018 Jun.
4
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.02337-2016. Print 2017 Aug.
5
Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.
Am J Respir Crit Care Med. 2017 Feb 1;195(3):360-368. doi: 10.1164/rccm.201605-1024OC.
6
18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.
J Nucl Med. 2016 Aug;57(8):1269-75. doi: 10.2967/jnumed.116.175596. Epub 2016 Jun 15.
7
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.
Am J Respir Crit Care Med. 2016 May 15;193(10):1168-75. doi: 10.1164/rccm.201509-1785OC.
8
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.
Circulation. 2016 Jan 5;133(1):82-97. doi: 10.1161/CIRCULATIONAHA.115.016133. Epub 2015 Oct 20.
9
Oestrogen receptor alpha in pulmonary hypertension.
Cardiovasc Res. 2015 May 1;106(2):206-16. doi: 10.1093/cvr/cvv106. Epub 2015 Mar 12.
10
Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.
Cytometry A. 2015 Jan;87(1):5-19. doi: 10.1002/cyto.a.22596. Epub 2014 Nov 21.
Zotero 插件